What is the Return on Assets (ROA) of BioArctic this year?
The Return on Assets (ROA) of BioArctic is 0.19 undefined this year.
BioArctic ROA 2024
BioArctic ROA
0.19
Ticker
BIOA B.ST
ISIN
SE0010323311
WKN
A2H5GS
In 2024, BioArctic's return on assets (ROA) was 0.19, a -1,584% increase from the -0.01 ROA in the previous year.
BioArctic Aktienanalyse
What does BioArctic do?
BioArctic AB is a Swedish biotechnology company founded in 2003. The company is based in Stockholm and focuses on the development of innovative therapeutics for nervous system diseases such as Alzheimer's, Parkinson's, and spinal cord injuries. The company uses its expertise in biological and chemical drug research to discover and develop new therapeutic possibilities, with a focus on Amyloid-Beta production. BioArctic's business strategy is based on partnerships with pharmaceutical and biotech companies worldwide, working closely with partners to develop therapies and products that meet the needs and expectations of patients and doctors. BioArctic conducts research in three different areas: Alzheimer's, Parkinson's, and spinal cord injuries. The company works with partners such as Nutricia, Eisai, Just Biotherapeutics, Abcam, Neuropharm, AbbVie, Q-Med, Uppsala University, and the Karolinska Institute to develop treatments for these conditions. BioArctic has already brought several promising products to market, including BAN2401 for Alzheimer's and SC0806 for spinal cord injuries. Overall, BioArctic is a leading company in biological and chemical drug research, with a focus on developing new therapies and products for the benefit of patients and doctors worldwide. BioArctic ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding BioArctic's Return on Assets (ROA)
BioArctic's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing BioArctic's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider BioArctic's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in BioArctic’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about BioArctic stock
What was the ROA of BioArctic compared to the previous year?
The ROA of BioArctic has increased by -1,584% compared to the previous year.
What consequences do high ROA have for investors of BioArctic?
A high ROA is advantageous for investors of BioArctic, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in BioArctic?
A low ROA can be unfavorable for investors of BioArctic as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of BioArctic affect the company?
An increase in ROA of BioArctic can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of BioArctic impact the company?
A reduction in the ROA of BioArctic can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of BioArctic?
Some factors that can influence the ROA of BioArctic include revenue, operating costs, asset structure, and industry average.
Why is the ROA of BioArctic important for investors?
The ROA of BioArctic is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can BioArctic take to improve ROA?
To improve ROA, BioArctic can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does BioArctic pay?
Over the past 12 months, BioArctic paid a dividend of 1.5 SEK . This corresponds to a dividend yield of about 0.83 %. For the coming 12 months, BioArctic is expected to pay a dividend of 4.63 SEK.
What is the dividend yield of BioArctic?
The current dividend yield of BioArctic is 0.83 %.
When does BioArctic pay dividends?
BioArctic pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of BioArctic?
BioArctic paid dividends every year for the past 4 years.
What is the dividend of BioArctic?
For the upcoming 12 months, dividends amounting to 4.63 SEK are expected. This corresponds to a dividend yield of 2.57 %.
In which sector is BioArctic located?
BioArctic is assigned to the 'Health' sector.
Wann musste ich die Aktien von BioArctic kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of BioArctic from 5/16/2019 amounting to 1.5 SEK, you needed to have the stock in your portfolio before the ex-date on 5/10/2019.
When did BioArctic pay the last dividend?
The last dividend was paid out on 5/16/2019.
What was the dividend of BioArctic in the year 2023?
In the year 2023, BioArctic distributed 0 SEK as dividends.
In which currency does BioArctic pay out the dividend?
The dividends of BioArctic are distributed in SEK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von BioArctic
Our stock analysis for BioArctic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioArctic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
